Related Experiment Video
Updated: Mar 20, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Roles of aldosterone in vascular calcification: An update
Jingwei Gao1, Kun Zhang1, Jie Chen2
1Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120 China; Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Guangzhou 510120, China.
Insights
Aldosterone promotes vascular calcification (VC), a common issue in chronic kidney disease and diabetes. Targeting aldosterone offers a potential new treatment strategy for preventing cardiovascular events associated with VC.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Endocrinology
Background:
- Vascular calcification (VC) is a prevalent pathology in chronic diseases like chronic kidney disease (CKD) and diabetes.
- VC is an independent risk factor for cardiovascular events.
- Current therapies for VC have limited efficacy due to its complex pathogenesis.
Purpose of the Study:
- To investigate the role of aldosterone (Aldo) in the pathogenesis of vascular calcification.
- To explore aldosterone as a potential therapeutic target for treating VC.
Main Methods:
- Review of clinical and experimental studies on aldosterone and vascular calcification.
- Analysis of genomic and non-genomic effects of aldosterone on the cardiovascular system.
Main Results:
- Aldosterone (Aldo) has been shown to promote vascular calcification (VC).
- Aldosterone exerts both genomic and non-genomic effects on cardiovascular tissues.
- Findings suggest aldosterone's involvement in the complex mechanisms of VC.
Conclusions:
- Aldosterone plays a significant role in promoting vascular calcification.
- Targeting aldosterone presents a promising therapeutic strategy for managing VC and associated cardiovascular risks.
Abstract:
Both clinical and experimental studies have demonstrated that vascular calcification (VC) is a common pathology shared in many chronic diseases such as chronic kidney disease (CKD) and diabetes. It's an independent risk factor for cardiovascular events. Since the pathogenesis of VC is complicated, current therapies have limited effects on the regression of VC. Therefore, it is urgent to investigate the potential mechanisms and find new targets for the treatment of VC. Aldosterone (Aldo), a mineralocorticoid hormone, is the metabolite of renin-angiotensin-aldosterone system (RAAS) activation, which can exert genomic and non-genomic effects on the cardiovascular system. Recent data suggests that Aldo can promote VC. Here, we summarized the roles of Aldo in the process of VC and a series of findings indicated that Aldo could act as a potentially therapeutic target for treating VC.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Skeleton and Calcium Homeostasis
Hormonal Regulation
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

